Aarey Drugs and Pharmaceuticals Ltd
Thu 13/03/2025,15:58:14 | NSE : AAREYDRUGS
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 36.30
Previous Close
₹ 37.18
Volume
68205
Mkt Cap ( Rs. Cr)
₹103.52
High
₹ 40.80
Low
₹ 35.91
52 Week High
₹ 74.80
52 Week Low
₹ 35.70
Book Value Per Share
₹ 46.93
Dividend Yield
0.00
Face Value
₹ 10.00
What’s Your Call?
Collective community sentiment on Aarey Drugs and Pharmaceuticals Ltd
Your Vote -
Buy
71.43%
Hold
14.29%
Sell
14.29%
71.43%
28 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
100%
Sell Order Quantity
0%
Bid Price
Qty
36.51
2
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
2
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Aarey Drugs and Pharmaceuticals Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Aarey Drugs & Ph - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Aarey Drugs & Ph - Change in Company Secretary/Compliance Officer
-
Aarey Drugs & Ph - Change in Company Secretary/Compliance Officer
-
Aarey Drugs & Ph - Outcome of Board Meeting
-
Aarey Drugs & Ph - Announcement under Regulation 30 (LODR)-Change in Management
-
Aarey Drugs & Ph - Appointment of Company Secretary and Compliance Officer
-
Aarey Drugs & Ph - Board Meeting Outcome for Intimation Regarding Appointment Of 'Company Secretary And Compliance Officer'
-
Aarey Drugs & Ph - Board Meeting Outcome for Intimation Regarding Appointment Of 'Company Secretary And Compliance Officer'
-
Aarey Drugs & Ph - Board Meeting Outcome for Intimation Regarding Appointment Of 'Company Secretary And Compliance Officer'
-
Aarey Drugs & Ph - Board Meeting Outcome for Intimation Regarding Appointment Of 'Company Secretary And Compliance Officer'
-
Aarey Drugs & Ph - Board Meeting Outcome for Intimation Regarding Appointment Of 'Company Secretary And Compliance Officer'
-
Aarey Drugs & Ph - Board Meeting Outcome for Intimation Regarding Appointment Of 'Company Secretary And Compliance Officer'
-
Aarey Drugs & Ph - Board Meeting Outcome for Intimation Regarding Appointment Of 'Company Secretary And Compliance Officer'
-
Aarey Drugs & Ph - Board Meeting Outcome for Intimation Regarding Appointment Of 'Company Secretary And Compliance Officer'
-
Aarey Drugs & Ph - Integrated Filing- Financial
-
Aarey Drugs & Ph - Integrated Filing (Financial)
-
Aarey Drugs & Ph Q3 net profit down 29.41% at Rs 0.72 cr
-
Aarey Drugs & Ph - Unaudited Financial Result For December 2024
-
Aarey Drugs & Ph - Financial Result Updates
-
Aarey Drugs & Ph - Board Meeting Outcome for Outcome
-
Aarey Drugs & Ph - Board Meeting Intimation
-
Aarey Drugs & Ph - Board Meeting Intimation for Quarterly Financial Result
-
Aarey Drugs & Ph has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2024
-
Aarey Drugs & Ph - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
Aarey Drugs & Ph - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Aarey Drugs & Ph - General Updates
-
Aarey Drugs & Ph - Announcement under Regulation 30 (LODR)-Change in RTA
-
Aarey Drugs & Ph - Resignation
-
Aarey Drugs & Ph - Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Aarey Drugs & Ph - Outcome of Board Meeting
-
Aarey Drugs & Ph - Shareholders meeting
-
Aarey Drugs & Ph - Announcement under Regulation 30 (LODR)-Cessation
-
Aarey Drugs & Ph - Board Meeting Outcome for Outcome
-
Aarey Drugs & Ph - Copy of Newspaper Publication
-
Aarey Drugs & Ph - Corrigendum
-
Aarey Drugs & Ph - Corrigendum
-
Aarey Drugs & Ph - Trading Window-XBRL
-
Aarey Drugs & Ph - Trading Window
-
Aarey Drugs board to reconsider stock split
Key fundamentals
Evaluate the intrinsic value of Aarey Drugs and Pharmaceuticals Ltd stock
| Name | March-24 | March-23 | March-22 | March-21 | March-20 |
|---|---|---|---|---|---|
| Assets | 164.1257 | 155.1265 | 127.7997 | 116.8776 | 110.2337 |
| Liabilities | 164.1257 | 155.1265 | 127.7997 | 116.8776 | 110.2337 |
| Equity | 28.0543 | 25.3847 | 25.3846 | 23.3846 | 23.3846 |
| Gross Profit | 4.4513 | 7.7213 | 11.2678 | 4.6387 | 3.2321 |
| Net Profit | 4.6837 | 3.7712 | 6.5447 | 6.5143 | 5.7935 |
| Cash From Operating Activities | -2.9938 | -1.2811 | -4.493 | 5.4769 | 2.8572 |
| NPM(%) | 1.18 | 0.9 | 1.32 | 1.86 | 1.93 |
| Revenue | 395.6179 | 418.9562 | 492.6799 | 348.4164 | 300.0888 |
| Expenses | 391.1666 | 411.2349 | 481.4121 | 343.7776 | 296.8566 |
| ROE(%) | 3.51 | 2.83 | 4.91 | 4.89 | 4.35 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Aarey Drugs and Pharmaceuticals Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 808.20 | -1.14 | 11.41 | 20.83 | 1321.50 | 1.42 |
| Lotus Eye Hospital and Institute Ltd | 57.06 | -0.77 | 237.75 | 75.89 | 14.01 | 0.88 |
| Vaishali Pharma Ltd | 12.12 | -5.90 | 606.00 | 39.11 | 2.31 | 0.00 |
| Astec Lifesciences Ltd | 653.90 | -5.55 | 0.00 | 71.55 | -239.30 | 0.00 |
Company Info
Aarey Drugs & Pharmaceuticals Ltd. (ADPL) was originally incorporated as a private limited company in the name of Niharika Textiles & Chemicals Pvt. Ltd. on 15th May 1990. The Aarey group of companie belonging to the Ghatalia group of companies took over the company and converted it into a public limited company on 18th march 1993. Its name was since changed to Aarey Drugs & Pharmaceuticals Ltd. The main object of the company is to set up facilities for manufacture of bulk drugs. As an immediate step the company has undertaken a project to manufacture Metronidazole and Metronidazole Benzoate at its works situated at E-34, MIDC Estate. 2008 -Aarey Drugs & Pharmaceuticals Ltd has appointed Mr. Chetan Kiritbhai Mehta as an Independent Director of the Company from June 02, 2008. 2012 -Aarey Drugs & Pharmaceuticals Ltd Issues Rights in the Ratio of 2:1 -Aarey Drugs & Pharmaceuticals has given the Bonus in the Ratio of 1:5 2017 -The company has commenced production of new line of product Mefanamic Acid and has confirmed order for the same from its customers up till October, 2017.
Aarey Drugs & Pharmaceuticals Ltd. (ADPL) was originally incorporated as a private limited company in the name of Niharika Textiles & Chemicals Pvt. Ltd. on 15th May 1990. The Aarey group of companie belonging to the Ghatalia group of companies took over the company and converted it into a public limited company on 18th march 1993. Its name was since changed to Aarey Drugs & Pharmaceuticals Ltd. The main object of the company is to set up facilities for manufacture of bulk drugs. As an immediate step the company has undertaken a project to manufacture Metronidazole and Metronidazole Benzoate at its works situated at E-34, MIDC Estate. 2008 -Aarey Drugs & Pharmaceuticals Ltd has appointed Mr. Chetan Kiritbhai Mehta as an Independent Director of the Company from June 02, 2008. 2012 -Aarey Drugs & Pharmaceuticals Ltd Issues Rights in the Ratio of 2:1 -Aarey Drugs & Pharmaceuticals has given the Bonus in the Ratio of 1:5 2017 -The company has commenced production of new line of product Mefanamic Acid and has confirmed order for the same from its customers up till October, 2017.
Read More
Parent Organisation
Aarey Drugs & Pharmaceuticals Ltd.
Founded
15/05/1990
Managing Director
Mr.Mihir R Ghatalia
NSE Symbol
AAREYDRUGSEQ
FAQ
The current price of Aarey Drugs and Pharmaceuticals Ltd is ₹ 36.51.
The 52-week high for Aarey Drugs and Pharmaceuticals Ltd is ₹ 40.80 and the 52-week low is ₹ 35.91.
The market capitalization of Aarey Drugs and Pharmaceuticals Ltd is currently ₹ 103.52. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Aarey Drugs and Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Aarey Drugs and Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Aarey Drugs and Pharmaceuticals Ltd shares.
The CEO of Aarey Drugs and Pharmaceuticals Ltd is Mr.Mihir R Ghatalia, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
